Detection of tamoxifen metabolites by GC-MSD.
Tamoxifen is an antiestrogen used in the adjuvant endocrine therapy of early breast cancer and malignant breast disorders. It is also used in women with anovulatory infertility caused by its stimulating effect on the secretion of the pituitary gonadotrophic hormones. In males it could increase the endogenous production of androgens. Because of these properties tamoxifen may be misused in some sports to treat the androgens suppression caused by the extensive abuse of anabolic androgenic steroids. A method for identification and confirmation of tamoxifen metabolites is described. Hydroxymetoxytamoxifen is detected in urine by gas chromatography and mass spectrometry in a selective ion monitoring method followed by the routine postrun in the screening of anabolic steroids. Once the hydroxymetoxytamoxifen is detected, confirmation of reported metabolites could be performed with a 5973 mass selective detector in the scan mode after solid-phase extraction by cationic exchange. This study also reports an excretion profile for a single dose of tamoxifen equivalent to 40 mg administrated orally to two males volunteers.
Báez
H
H
Laboratorio de Análisis Antidoping, Facultad Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile.
Camargo
C
C
Osorio
H
H
Umpiérrez
F
F
D000328:Adult; D020847:Estrogen Receptor Modulators / Q000378:metabolism* / Q000493:pharmacokinetics; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods*; D006801:Humans; D008297:Male; D013629:Tamoxifen / Q000378:metabolism* / Q000493:pharmacokinetics
D020847:Estrogen Receptor Modulators; D013629:Tamoxifen